<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32546239</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1741-7015</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>17</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>153</StartPage><MedlinePgn>153</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">153</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12916-020-01607-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">A connection between amyotrophic lateral sclerosis (ALS) and altered gut microbiota composition has previously been reported in animal models. This work is the first prospective longitudinal study addressing the microbiota composition in ALS patients and the impact of a probiotic supplementation on the gut microbiota and disease progression.</AbstractText><AbstractText Label="METHODS">Fifty patients and 50 matched controls were enrolled. The microbial profile of stool samples from patients and controls was analyzed via PCR-Denaturing Gradient Gel Electrophoresis, and the main microbial groups quantified via qPCR. The whole microbiota was then analyzed via next generation sequencing after amplification of the V3-V4 region of 16S rDNA. Patients were then randomized to receive probiotic treatment or placebo and followed up for 6&#x2009;months with ALSFRS-R, BMI, and FVC%.</AbstractText><AbstractText Label="RESULTS">The results demonstrate that the gut microbiota of ALS patients is characterized by some differences with respect to controls, regardless of the disability degree. Moreover, the gut microbiota composition changes during the course of the disease as demonstrated by the significant decrease in the number of observed operational taxonomic unit during the follow-up. Interestingly, an unbalance between potentially protective microbial groups, such as Bacteroidetes, and other with potential neurotoxic or pro-inflammatory activity, such as Cyanobacteria, has been shown. The 6-month probiotic treatment influenced the gut microbial composition; however, it did not bring the biodiversity of intestinal microbiota of patients closer to that of control subjects and no influence on the progression of the disease measured by ALSFRS-R was demonstrated.</AbstractText><AbstractText Label="CONCLUSIONS">Our study poses the bases for larger clinical studies to characterize the microbiota changes as a novel ALS biomarker and to test new microbial strategy to ameliorate the health status of the gut.</AbstractText><AbstractText Label="TRIAL REGISTRATION">CE 107/14, approved by the Ethics Committee of the "Maggiore della Carit&#xe0;" University Hospital, Italy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Di Gioia</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Agricultural and Food Sciences, University of Bologna, Viale Fanin 42, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozzi Cionci</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Agricultural and Food Sciences, University of Bologna, Viale Fanin 42, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baffoni</LastName><ForeName>Loredana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Agricultural and Food Sciences, University of Bologna, Viale Fanin 42, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amoruso</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>BIOLAB RESEARCH srl, via E. Mattei 3, 28100, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pane</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>BIOLAB RESEARCH srl, via E. Mattei 3, 28100, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mogna</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>BIOLAB RESEARCH srl, via E. Mattei 3, 28100, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagg&#xec;a</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Agricultural and Food Sciences, University of Bologna, Viale Fanin 42, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucenti</LastName><ForeName>Maria Ausiliatrice</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Neurology and ALS Centre, University of Piemonte Orientale, Maggiore della Carit&#xe0; Hospital, Corso Mazzini 18, 28100, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bersano</LastName><ForeName>Enrica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology and ALS Centre, University of Piemonte Orientale, Maggiore della Carit&#xe0; Hospital, Corso Mazzini 18, 28100, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantello</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology and ALS Centre, University of Piemonte Orientale, Maggiore della Carit&#xe0; Hospital, Corso Mazzini 18, 28100, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Marchi</LastName><ForeName>Fabiola</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology and ALS Centre, University of Piemonte Orientale, Maggiore della Carit&#xe0; Hospital, Corso Mazzini 18, 28100, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzini</LastName><ForeName>Letizia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology and ALS Centre, University of Piemonte Orientale, Maggiore della Carit&#xe0; Hospital, Corso Mazzini 18, 28100, Novara, Italy. letizia.mazzini@uniupo.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>--</GrantID><Agency>Probiotical S.p.A.</Agency><Country>International</Country></Grant><Grant><GrantID>AGING Project for Department of Excellence at the Department of Translational Medicine (DIMET), Universit&#xe0; del Piemonte Orientale, Novara, Italy</GrantID><Agency>Universit&#xe0; degli Studi del Piemonte Orientale</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Microbiota</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword></KeywordList><CoiStatement>A.A. and M.P. are funded by Probiotical S.p.A. All other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32546239</ArticleId><ArticleId IdType="pmc">PMC7298784</ArticleId><ArticleId IdType="doi">10.1186/s12916-020-01607-9</ArticleId><ArticleId IdType="pii">10.1186/s12916-020-01607-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Prim. 2017;3:17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Stilling RM, Dinan TG, Cryan JF. Microbial genes, brain &amp; behaviour&#x2013;epigenetic regulation of the gut&#x2013;brain axis. Genes, Brain Behav. 2014;13(1):69&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">24286462</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheperjans F, Aho V, Pereira PAB, Koskinen K, Paulin L, Pekkonen E, et al. Gut microbiota are related to Parkinson&#x2019;s disease and clinical phenotype. Mov Disord. 2015;30(3):350&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pubmed">25476529</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin A, Zheng W, He Y, Tang W, Wei X, He R, et al. Gut microbiota in patients with Parkinson&#x2019;s disease in southern China. Parkinsonism Relat Disord. 2018;53:82&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">29776865</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang Z-Q, Shen L-L, Li W-W, Fu X, Zeng F, Gui L, et al. Gut microbiota is altered in patients with Alzheimer&#x2019;s disease. J Alzheimers Dis. 2018;63(4):1337&#x2013;1346.</Citation><ArticleIdList><ArticleId IdType="pubmed">29758946</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Soldan MMP, et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep. 2016;6:28484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4921909</ArticleId><ArticleId IdType="pubmed">27346372</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang C, Li G, Huang P, Liu Z, Zhao B. The gut microbiota and Alzheimer&#x2019;s disease. J Alzheimers Dis. 2017;58(1):1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">28372330</ArticleId></ArticleIdList></Reference><Reference><Citation>Jangi S, Gandhi R, Cox LM, Li N, Von Glehn F, Yan R, et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016;7:12015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4931233</ArticleId><ArticleId IdType="pubmed">27352007</ArticleId></ArticleIdList></Reference><Reference><Citation>Longstreth WT, Jr, Meschke JS, Davidson SK, Smoot LM, Smoot JC, Koepsell TD. Hypothesis: a motor neuron toxin produced by a clostridial species residing in gut causes ALS. Med Hypotheses. 2005;64(6):1153&#x2013;1156.</Citation><ArticleIdList><ArticleId IdType="pubmed">15823706</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572(7770):474&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pubmed">31330533</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, Hiergeist A, Adis C, Mayer B, Gessner A, Ludolph AC, et al. The fecal microbiome of ALS patients. Neurobiol Aging. 2018;61:132&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">29065369</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowin Julie, Xia Yinglin, Jung Barbara, Sun Jun. Gut inflammation and dysbiosis in human motor neuron disease. Physiological Reports. 2017;5(18):e13443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5617930</ArticleId><ArticleId IdType="pubmed">28947596</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, et al. A revision of the El Escorial criteria-2015. Amyotroph Lateral Scler Front Degener. 2015;16(5&#x2013;6):291&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Deidda F, Amoruso A, Nicola S, Graziano T, Pane M, Allesina S, et al. The in vitro effectiveness of Lactobacillus fermentum against different Candida species compared with broadly used azoles. J Clin Gastroenterol. 2016;50:S171&#x2013;S174.</Citation><ArticleIdList><ArticleId IdType="pubmed">27741168</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogna L, Del Piano M, Deidda F, Nicola S, Soattini L, Debiaggi R, et al. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains. J Clin Gastroenterol. 2012;46:S29&#x2013;S32.</Citation><ArticleIdList><ArticleId IdType="pubmed">22955353</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogna L, Deidda F, Nicola S, Amoruso A, Del Piano M, Mogna G. In vitro inhibition of Klebsiella pneumoniae by Lactobacillus delbrueckii subsp. delbrueckii LDD01 (DSM 22106): an innovative strategy to possibly counteract such infections in humans? J Clin Gastroenterol. 2016;50:S136&#x2013;S139.</Citation><ArticleIdList><ArticleId IdType="pubmed">27741158</ArticleId></ArticleIdList></Reference><Reference><Citation>Deidda F, Amoruso A, Nicola S, Graziano T, Pane M, Mogna L. New approach in acne therapy: a specific bacteriocin activity and a targeted anti IL-8 property in just 1 probiotic strain, the L. salivarius LS03. J Clin Gastroenterol. 2018;52:S78&#x2013;S81.</Citation><ArticleIdList><ArticleId IdType="pubmed">29782471</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloisio I, Mazzola G, Corvaglia LT, Tonti G, Faldella G, Biavati B, et al. Influence of intrapartum antibiotic prophylaxis against group B Streptococcus on the early newborn gut composition and evaluation of the anti-Streptococcus activity of Bifidobacterium strains. Appl Microbiol Biotechnol. 2014;98(13):6051&#x2013;6060.</Citation><ArticleIdList><ArticleId IdType="pubmed">24687755</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X, Xia X, Tang R, Wang K. Real-time PCR quantification of the predominant bacterial divisions in the distal gut of Meishan and Landrace pigs. Anaerobe. 2008;14(4):224&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">18524640</ArticleId></ArticleIdList></Reference><Reference><Citation>Hierro N, Esteve-Zarzoso B, Gonz&#xe1;lez &#xc1;, Mas A, Guillam&#xf3;n JM. Real-time quantitative PCR (QPCR) and reverse transcription-QPCR for detection and enumeration of total yeasts in wine. Appl Environ Microbiol. 2006;72(11):7148&#x2013;7155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1636171</ArticleId><ArticleId IdType="pubmed">17088381</ArticleId></ArticleIdList></Reference><Reference><Citation>Malinen E, Kassinen A, Rinttil&#xe4; T, Palva A. Comparison of real-time PCR with SYBR Green I or 5&#x2032;-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology. 2003;149(1):269&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">12576600</ArticleId></ArticleIdList></Reference><Reference><Citation>Quagliariello A, Aloisio I, Bozzi Cionci N, Luiselli D, D&#x2019;Auria G, Martinez-Priego L, et al. Effect of Bifidobacterium breve on the intestinal microbiota of coeliac children on a gluten free diet: a pilot study. Nutrients. 2016;8(10):660.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5084046</ArticleId><ArticleId IdType="pubmed">27782071</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloisio I, Prodam F, Giglione E, Bozzi Cionci N, Solito A, Bellone S, et al. Three-month feeding integration with bifidobacterium strains prevents gastrointestinal symptoms in healthy newborns. Front Nutr. 2018;5:39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5980983</ArticleId><ArticleId IdType="pubmed">29888226</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee ZM-P, Bussema C, III, Schmidt TM. rrn DB: documenting the number of rRNA and tRNA genes in bacteria and archaea. Nucleic Acids Res. 2008;37(suppl_1):D489&#x2013;D493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2686494</ArticleId><ArticleId IdType="pubmed">18948294</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuyts J, Perriere G, Van de Peer Y. The European ribosomal RNA database. Nucleic Acids Res. 2004;32(suppl_1):D101&#x2013;D103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308799</ArticleId><ArticleId IdType="pubmed">14681368</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoddard SF, Smith BJ, Hein R, Roller BRK, Schmidt TM. rrn DB: improved tools for interpreting rRNA gene abundance in bacteria and archaea and a new foundation for future development. Nucleic Acids Res. 2014;43(D1):D593&#x2013;D598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383981</ArticleId><ArticleId IdType="pubmed">25414355</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocolin L, Aggio D, Manzano M, Cantoni C, Comi G. An application of PCR-DGGE analysis to profile the yeast populations in raw milk. Int Dairy J. 2002;12(5):407&#x2013;411.</Citation></Reference><Reference><Citation>Walter J, Tannock GW, Tilsala-Timisjarvi A, Rodtong S, Loach DM, Munro K, et al. Detection and identification of gastrointestinallactobacillus species by using denaturing gradient gel electrophoresis and species-specific pcr primers. Appl Environ Microbiol. 2000;66(1):297&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC91821</ArticleId><ArticleId IdType="pubmed">10618239</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagg&#xec;a F, Baffoni L, Stenico V, Alberoni D, Buglione E, Lilli A, et al. Microbial investigation on honey bee larvae showing atypical symptoms of European foulbrood. Bull Insectology. 2015;68(2):321&#x2013;327.</Citation></Reference><Reference><Citation>Takahashi S, Tomita J, Nishioka K, Hisada T, Nishijima M. Development of a prokaryotic universal primer for simultaneous analysis of bacteria and archaea using next-generation sequencing. PLoS One. 2014;9(8):e105592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4140814</ArticleId><ArticleId IdType="pubmed">25144201</ArticleId></ArticleIdList></Reference><Reference><Citation>Mago&#x10d; T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 2011;27(21):2957&#x2013;2963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3198573</ArticleId><ArticleId IdType="pubmed">21903629</ArticleId></ArticleIdList></Reference><Reference><Citation>Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3156573</ArticleId><ArticleId IdType="pubmed">20383131</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas BJ, Gevers D, Earl AM, Feldgarden M, Ward DV, Giannoukos G, et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 2011;21(3):494&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3044863</ArticleId><ArticleId IdType="pubmed">21212162</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26(19):2460&#x2013;2461.</Citation><ArticleIdList><ArticleId IdType="pubmed">20709691</ArticleId></ArticleIdList></Reference><Reference><Citation>Caporaso JG, Bittinger K, Bushman FD, DeSantis TZ, Andersen GL, Knight R. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics. 2009;26(2):266&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2804299</ArticleId><ArticleId IdType="pubmed">19914921</ArticleId></ArticleIdList></Reference><Reference><Citation>Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2012;41(D1):D590&#x2013;D596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3531112</ArticleId><ArticleId IdType="pubmed">23193283</ArticleId></ArticleIdList></Reference><Reference><Citation>Hevia A, Milani C, L&#xf3;pez P, Cuervo A, Arboleya S, Duranti S, et al. Intestinal dysbiosis associated with systemic lupus erythematosus. MBio. 2014;5(5):e01548&#x2013;e01514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4196225</ArticleId><ArticleId IdType="pubmed">25271284</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Zhan Y., Mariosa D., Larsson H., Almqvist C., Ingre C., Zagai U., Pawitan Y., Fang F. Antibiotics use and risk of amyotrophic lateral sclerosis in Sweden. European Journal of Neurology. 2019;26(11):1355&#x2013;1361.</Citation><ArticleIdList><ArticleId IdType="pubmed">31087715</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S, Saporta S, Haller E, Kolomey I, Bennett SP, Potter H, et al. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One. 2007;2(11):e1205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2075163</ArticleId><ArticleId IdType="pubmed">18030339</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokol H, Leducq V, Aschard H, Pham H-P, Jegou S, Landman C, et al. Fungal microbiota dysbiosis in IBD. Gut. 2017;66(6):1039&#x2013;1048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5532459</ArticleId><ArticleId IdType="pubmed">26843508</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3779803</ArticleId><ArticleId IdType="pubmed">20203603</ArticleId></ArticleIdList></Reference><Reference><Citation>Banack SA, Cox PA. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Neurology. 2003;61(3):387&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pubmed">12913204</ArticleId></ArticleIdList></Reference><Reference><Citation>Banack SA, Murch SJ, Cox PA. Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands. J Ethnopharmacol. 2006;106(1):97&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">16457975</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox PA, Sacks OW. Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. Neurology. 2002;58(6):956&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pubmed">11914415</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox PA, Banack SA, Murch SJ. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc Natl Acad Sci. 2003;100(23):13380&#x2013;13383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC263822</ArticleId><ArticleId IdType="pubmed">14612559</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox PA, Banack SA, Murch SJ. Cyanobacteria, cycads, and neurodegenerative disease among the Chamorro people of Guam. Mem N Y Bot Gard. 2007;97:253&#x2013;285.</Citation></Reference><Reference><Citation>Murch SJ, Cox PA, Banack SA. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc Natl Acad Sci. 2004;101(33):12228&#x2013;12231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC514403</ArticleId><ArticleId IdType="pubmed">15295100</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman SM, Olney JW. Excitotoxicity and the NMDA receptor--still lethal after eight years. Trends Neurosci. 1995;18(2):57&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">7537407</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownson DM, Mabry TJ, Leslie SW. The cycad neurotoxic amino acid, &#xdf;-N-methylamino-l-alanine (BMAA), elevates intracellular calcium levels in dissociated rat brain cells. J Ethnopharmacol. 2002;82(2&#x2013;3):159&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">12241991</ArticleId></ArticleIdList></Reference><Reference><Citation>Buenz EJ, Howe CL. Beta-methylamino-alanine (BMAA) injures hippocampal neurons in vivo. Neurotoxicology. 2007;28(3):702&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">17379313</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao SD, Banack SA, Cox PA, Weiss JH. BMAA selectively injures motor neurons via AMPA/kainate receptor activation. Exp Neurol. 2006;201(1):244&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">16764863</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer PS, Nunn PB, Hugon J, Ludolph AC, Ross SM, Roy DN, et al. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science (80- ) 1987;237(4814):517&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pubmed">3603037</ArticleId></ArticleIdList></Reference><Reference><Citation>Cest&#xe8;le S, Catterall WA. Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. Biochimie. 2000;82(9&#x2013;10):883&#x2013;892.</Citation><ArticleIdList><ArticleId IdType="pubmed">11086218</ArticleId></ArticleIdList></Reference><Reference><Citation>Llewellyn LE. Saxitoxin, a toxic marine natural product that targets a multitude of receptors. Nat Prod Rep. 2006;23(2):200&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">16572228</ArticleId></ArticleIdList></Reference><Reference><Citation>Feurstein D, Stemmer K, Kleinteich J, Speicher T, Dietrich DR. Microcystin congener&#x2013;and concentration-dependent induction of murine neuron apoptosis and neurite degeneration. Toxicol Sci. 2011;124(2):424&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pubmed">21934130</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer WJ, Dietrich DR. Pathological and biochemical characterization of microcystin-induced hepatopancreas and kidney damage in carp (Cyprinus carpio) Toxicol Appl Pharmacol. 2000;164(1):73&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">10739746</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshizawa S, Matsushima R, Watanabe MF, Harada K, Ichihara A, Carmichael WW, et al. Inhibition of protein phosphatases by microcystis and nodularin associated with hepatotoxicity. J Cancer Res Clin Oncol. 1990;116(6):609&#x2013;614.</Citation><ArticleIdList><ArticleId IdType="pubmed">2174896</ArticleId></ArticleIdList></Reference><Reference><Citation>Derrien M, Van Baarlen P, Hooiveld G, Norin E, Muller M, de Vos W. Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila. Front Microbiol. 2011;2:166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3153965</ArticleId><ArticleId IdType="pubmed">21904534</ArticleId></ArticleIdList></Reference><Reference><Citation>Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science (80- ) 2011;331(6015):337&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3969237</ArticleId><ArticleId IdType="pubmed">21205640</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, Delaney ML, et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe. 2010;8(3):292&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2952357</ArticleId><ArticleId IdType="pubmed">20833380</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleessen B, Kroesen AJ, Buhr HJ, Blaut M. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol. 2002;37(9):1034&#x2013;1041.</Citation><ArticleIdList><ArticleId IdType="pubmed">12374228</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701.</Citation><ArticleIdList><ArticleId IdType="pubmed">22968153</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. 2015;48:186&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">25882912</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst. 2013;105(24):1907&#x2013;1911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3866154</ArticleId><ArticleId IdType="pubmed">24316595</ArticleId></ArticleIdList></Reference><Reference><Citation>De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, et al. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One. 2013;8(10):e76993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3793965</ArticleId><ArticleId IdType="pubmed">24130822</ArticleId></ArticleIdList></Reference><Reference><Citation>Parracho HMRT, Bingham MO, Gibson GR, McCartney AL. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol. 2005;54(10):987&#x2013;991.</Citation><ArticleIdList><ArticleId IdType="pubmed">16157555</ArticleId></ArticleIdList></Reference><Reference><Citation>Biddle A, Stewart L, Blanchard J, Leschine S. Untangling the genetic basis of fibrolytic specialization by Lachnospiraceae and Ruminococcaceae in diverse gut communities. Diversity. 2013;5(3):627&#x2013;640.</Citation></Reference><Reference><Citation>Yu Z-T, Yao W, Zhu W-Y. Isolation and identification of equol-producing bacterial strains from cultures of pig faeces. FEMS Microbiol Lett. 2008;282(1):73&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">18328079</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu W, Wang Y, Zhou D-X, Zhao L-M, Li G-R, Deng X-L. Equol is neuroprotective during focal cerebral ischemia and reperfusion that involves p-Src and gp91phox. Curr Neurovasc Res. 2014;11(4):367&#x2013;377.</Citation><ArticleIdList><ArticleId IdType="pubmed">25198009</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins JW, Keeney KM, Crepin VF, Rathinam VAK, Fitzgerald KA, Finlay BB, et al. Citrobacter rodentium: infection, inflammation and the microbiota. Nat Rev Microbiol. 2014;12(9):612.</Citation><ArticleIdList><ArticleId IdType="pubmed">25088150</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe. 2007;2(2):119&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">18005726</ArticleId></ArticleIdList></Reference><Reference><Citation>Louis S, Tappu R-M, Damms-Machado A, Huson DH, Bischoff SC. Characterization of the gut microbial community of obese patients following a weight-loss intervention using whole metagenome shotgun sequencing. PLoS One. 2016;11(2):e0149564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4769288</ArticleId><ArticleId IdType="pubmed">26919743</ArticleId></ArticleIdList></Reference><Reference><Citation>Park Y, Park J, Kim Y, Baek H, Kim SH. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients. Nutrition. 2015;31(11&#x2013;12):1362&#x2013;1367.</Citation><ArticleIdList><ArticleId IdType="pubmed">26429656</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013;74(10):720&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pubmed">23759244</ArticleId></ArticleIdList></Reference><Reference><Citation>Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19(1):29&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">27928878</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen SJ, Wareham K, Wang D, Bradley C, Hutchings H, Harris W, et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2013;382(9900):1249&#x2013;1257.</Citation><ArticleIdList><ArticleId IdType="pubmed">23932219</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE. Dose&#x2013;response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol. 2010;105(7):1636.</Citation><ArticleIdList><ArticleId IdType="pubmed">20145608</ArticleId></ArticleIdList></Reference><Reference><Citation>Naaber P, Smidt I, &#x160;t&#x161;epetova J, Brilene T, Annuk H, Mikelsaar M. Inhibition of Clostridium difficile strains by intestinal Lactobacillus species. J Med Microbiol. 2004;53(6):551&#x2013;554.</Citation><ArticleIdList><ArticleId IdType="pubmed">15150337</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston BC, Ma SSY, Goldenberg JZ, Thorlund K, Vandvik PO, Loeb M, et al. Probiotics for the prevention of Clostridium difficile&#x2013;associated diarrhea: a systematic review and meta-analysis. Ann Intern Med. 2012;157(12):878&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pubmed">23362517</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldenberg JZ, Yap C, Lytvyn L, Lo CK, Beardsley J, Mertz D, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6486212</ArticleId><ArticleId IdType="pubmed">29257353</ArticleId></ArticleIdList></Reference><Reference><Citation>De Wolfe TJ, Eggers S, Barker AK, Kates AE, Dill-McFarland KA, Suen G, et al. Oral probiotic combination of Lactobacillus and Bifidobacterium alters the gastrointestinal microbiota during antibiotic treatment for Clostridium difficile infection. PLoS One. 2018;13(9):e0204253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6161886</ArticleId><ArticleId IdType="pubmed">30265691</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, et al. Parkinson&#x2019;s disease and Parkinson&#x2019;s disease medications have distinct signatures of the gut microbiome. Mov Disord. 2017;32(5):739&#x2013;749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5469442</ArticleId><ArticleId IdType="pubmed">28195358</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas F, Hehemann J-H, Rebuffet E, Czjzek M, Michel G. Environmental and gut bacteroidetes: the food connection. Front Microbiol. 2011;2:93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3129010</ArticleId><ArticleId IdType="pubmed">21747801</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu Q, Li P, Hao S, Zhang Y, Kim SW, Li H, et al. Dynamic distribution of the gut microbiota and the relationship with apparent crude fiber digestibility and growth stages in pigs. Sci Rep. 2015;5:9938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4404679</ArticleId><ArticleId IdType="pubmed">25898122</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>